华熙生物 (688363.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(华熙生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,145,823,331.381,770,455,754.991,305,155,874.232,038,818,806.361,384,920,970.331,680,595,920.701,254,856,278.10
 营业收入(元) 1,145,823,331.381,770,455,754.991,305,155,874.232,038,818,806.361,384,920,970.331,680,595,920.701,254,856,278.10
二、营业总成本(元) 1,069,811,045.281,505,795,466.611,120,138,044.481,751,322,018.281,161,141,300.031,386,448,471.391,023,281,689.96
 营业成本(元) 330,799,604.63463,696,479.10342,188,052.59479,411,383.39321,333,199.25375,524,087.03286,958,174.40
 研发费用(元) 90,408,566.44103,547,183.3683,153,130.85110,921,777.5497,807,572.4597,977,253.0681,481,354.61
 营业税金及附加(元) 14,779,848.1720,584,076.249,395,960.2926,378,897.1313,563,965.9123,972,813.3113,280,428.54
 销售费用(元) 522,284,388.64814,712,363.40605,505,558.161,019,731,566.69642,663,233.16820,776,742.86566,195,184.91
 管理费用(元) 114,195,110.02119,534,767.1285,949,868.30120,156,324.8797,872,916.7496,367,020.2778,476,103.44
 财务费用(元) -2,656,472.62-16,279,402.61-6,054,525.71-5,277,931.34-12,099,587.48-28,169,445.14-3,109,555.94
  其中:利息费用(元) -835,958.214,353,088.671,609,222.972,855,685.872,243,035.952,044,756.802,003,895.36
  其中:利息收入(元) 8,250,445.4210,320,049.6411,026,526.8810,755,341.488,643,082.699,426,610.359,703,312.98
 资产减值损失(元) -3,602,334.51-1,527,660.561,316,968.69409,423.46-79,266.02-11,862,859.76-3,914,546.12
 信用减值损失(元) -1,196,630.83-5,980,604.89-4,178,280.61-10,470,960.02-685,466.19-1,162,706.69-6,391,541.99
三、其他经营收益
 加:公允价值变动收益(元) -24,683.33446,608.74-185,858.74-4,779,426.551,698,531.121,264,836.541,673,481.67
 加:投资收益(元) 256,547.41-263,554.581,860,834.814,161,312.023,286,010.032,991,759.251,476,143.12
  其中:对联营企业和合营企业的投资收益(元) -156,934.78-706,953.27-589,570.31-1,563,641.08-378,568.86-196,523.79-221,723.19
 资产处置收益(元) ----476,809.8868,399.99-74,108.52-6,162.00
 其他收益(元) 22,109,632.4017,157,347.5559,285,971.4937,439,544.1214,430,708.2752,795,904.0017,523,083.33
四、营业利润(元) 93,554,817.24274,492,424.64243,117,465.39313,779,871.23242,498,587.50338,100,274.13241,935,046.15
 加:营业外收入(元) 283,923.72800,972.86879,204.383,640,851.831,261,803.44874,161.98343,957.15
 减:营业外支出(元) 41,292.52411,981.532,248,074.58693,896.95754,000.724,598,062.45276,591.54
 利润总额平衡项目(元) -------0.01
五、利润总额(元) 93,797,448.44274,881,415.97241,748,595.19316,726,826.11243,006,390.22334,376,373.67242,002,411.75
 减:所得税费用(元) 8,276,377.8554,291,781.5840,776,322.2522,505,355.4242,768,334.3365,101,231.6344,356,874.30
六、净利润(元) 85,521,070.59220,589,634.39200,972,272.94294,221,470.69200,238,055.89269,275,142.03197,645,537.46
(一)按经营持续性分类
  持续经营净利润(元) 85,521,070.59220,589,634.39200,972,272.94294,221,470.69200,238,055.89269,275,142.03197,645,537.46
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 89,792,177.94224,123,331.15200,485,364.45293,478,596.45204,214,799.15273,474,318.96199,750,879.22
  少数股东损益(元) -4,271,107.35-3,533,696.75486,908.48742,874.24-3,976,743.26-4,199,176.93-2,105,341.76
 扣除非经常性损益后的净利润(元) 72,361,244.04209,550,953.63150,990,458.74251,109,470.01188,089,893.17230,058,229.13182,886,832.30
七、每股收益
 一、基本每股收益(元) 0.190.460.420.610.430.560.42
 二、稀释每股收益(元) 0.190.460.420.600.430.560.42
八、其他综合收益(元) -12,544,885.8020,946,486.04-610,303.4523,210,413.44-1,635,522.73-2,078,888.24-4,686,604.92
 归属于母公司股东的其他综合收益(元) -12,544,885.8020,946,486.04-610,303.4523,210,413.44-1,635,522.73-2,078,888.24-4,686,604.92
九、综合收益总额(元) 72,976,184.79241,536,120.43200,361,969.49317,431,884.13198,602,533.16267,196,253.79192,958,932.54
 归属于母公司所有者的综合收益总额(元) 77,247,292.14245,069,817.18199,875,061.01316,689,009.89202,579,276.42271,395,430.72195,064,274.30
 归属于少数股东的综合收益总额(元) -4,271,107.35-3,533,696.75486,908.48742,874.24-3,976,743.26-4,199,176.93-2,105,341.76
公告日期 2023-10-312023-08-302023-04-292023-03-312022-10-292022-08-302022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院